CD8A and metastatic neoplasm: Researchers have obtained 64 pairs of surgically removed primary tumours and metastatic tumours specimens from 28 NSCLC patients and found that metastatic tumours specimens exhibited higher PD-L1 expression and lower CD8+ cytotoxic T lymphocyte (CTLs) density.